Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Trial of Umbilical Cord Mesenchymal Stem Cells in Subacute Ischemic Stroke
Sponsor: Shanghai IxCell Biotechnology Co., LTD
Summary
The goal of this clinical trial is to evaluate the efficacy, safety, and pharmacodynamic characteristics of Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs) in adults with ischemic stroke in the anterior circulation during the recovery phase. Researchers will compare hUC-MSCs to a placebo to determine whether hUC-MSCs treatment is effective in treating recovery-phase anterior circulation ischemic stroke.
Official title: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study to Evaluate the Efficacy and Safety of IxCell hUC-MSC-S in Patients With Ischemic Stroke in the Recovery Phase
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
86
Start Date
2025-10-01
Completion Date
2027-12-31
Last Updated
2025-09-29
Healthy Volunteers
No
Conditions
Interventions
Placebo
Intravenous injection of placebo
IxCell hUC-MSC-S (Human Umbilical Cord Mesenchymal Stem Cells)
Intravenous injection of IxCell hUC-MSC-S
Locations (1)
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China